The Multifaceted Effects of Autophagy on the Tumor Microenvironment
- 7 February 2020
- book chapter
- Published by Springer Nature
- Vol. 1225, 99-114
Abstract
The tumor microenvironment is composed of cancer cells, noncancer cells (e.g., immune cells, stromal cells, endothelial cells, and adipocytes), and various mediators (e.g., cytokines, chemokines, growth factors, and humoral factors) that work together to support cancer growth, progression, and resistance to therapies. Autophagy is an evolutionarily conserved degradation mechanism by which various cytosolic cargos (e.g., damaged organelles, unused molecules, or invaded pathogens) are engulfed by double-membrane autophagosomes, and then delivered into the lysosome for degradation and recycling. The level of autophagy is a crucial threshold to either promote cell survival or induce cell death in response to environmental stresses. Autophagy plays a context-dependent role in tumorigenesis and anticancer therapy via shaping the inflammatory, hypoxic, immunosuppressive, and metabolic tumor microenvironment. In particular, impaired autophagy flux is associated with chronic inflammation, immunosuppression, stromal formation, cancer stemness, angiogenesis, metastasis, and metabolic reprogramming in the tumor microenvironment. Understanding the molecular machinery of autophagy and its communication with hallmarks of cancer could lead to potential new anticancer strategies or drugs.Keywords
This publication has 180 references indexed in Scilit:
- Stromal–epithelial metabolic coupling in cancer: Integrating autophagy and metabolism in the tumor microenvironmentThe International Journal of Biochemistry & Cell Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The Beclin 1 network regulates autophagy and apoptosisCell Death & Differentiation, 2011
- Autophagy in immunity and inflammationNature, 2011
- Autophagy and the Integrated Stress ResponseMolecular Cell, 2010
- Eaten alive: a history of macroautophagyNature Cell Biology, 2010
- Autophagy regulates selective HMGB1 release in tumor cells that are destined to dieCell Death & Differentiation, 2008
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002